This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Surgical ablation of atrial fibrillation
AF_ABLATION
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
179 |
4. Check minimum number of eventsNone |
179 |
5. Include endpointsNone |
179 |
6. Filter based on genotype QC (FinnGen only) |
179 |
Control definitions (FinnGen only)
- Control exclude
- AF_OPER
Extra metadata
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
Surgical ablation of atrial fibrillation
based on the number of shared cases.
Similar with more cases:
- Operations for atrial fibrillation
- Other heart diseases
- Other heart diseases, wide
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 179 | 47 | 132 |
| Unadjusted period prevalence (%) | 0.05 | 0.02 | 0.06 |
| Median age at first event (years) | 65.14 | 66.41 | 64.69 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 165
- Matched controls
- 1651
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
FPD10
NOMESCO Finland
Surgical ablation of atrial fibrillation
+∞
238.6
165
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
148.2
128.4
132
43
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
58.2
99.8
128
92
I48
ICD-10 Finland
Atrial fibrillation and flutter
75.0
97.0
153
239
WX872
NOMESCO Finland
Intensive care
58.7
92.4
112
57
B01AA03
ATC
warfarin; systemic
36.5
81.4
141
228
FFM10
NOMESCO Finland
Occlusion or excision of atrial appendage externally with a closing device
619.2
77.7
71
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
33.3
74.7
145
294
I34.1
ICD-10 Finland
Mitral (valve) prolapse
84.6
73.7
80
18
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
167.8
63.2
63
6
TFP20
NOMESCO Finland
Cardiodefibrillation
26.5
63.1
95
80
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
45.3
55.4
68
25
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
15.6
54.0
113
201
C07AB07
ATC
bisoprolol; oral
37.0
51.7
158
625
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
14.5
51.0
109
195
207
Kela drug reimbursment
Chronic arrhythmias
15.0
50.1
100
153
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
13.2
46.1
98
164
FKC50
NOMESCO Finland
Repair of mitral valve for insufficiency using prosthetic chord
552.0
44.4
42
*
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
11.9
40.6
88
144
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
17.4
40.0
67
62
XF404
NOMESCO Finland
Ambulatory ECG
13.4
34.4
65
76
C01BD01
ATC
amiodarone; systemic
27.2
33.3
46
23
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
52.4
31.5
37
9
FFM30
NOMESCO Finland
Occlusion of atrial appendage internally by internal suture ligation
+∞
31.2
29
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
30.6
30.1
40
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
7.8
29.5
134
586
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
56.2
27.6
32
7
FKC60
NOMESCO Finland
Resection and reconstruction of leaflet of mitral valve for insufficiency
116.5
27.6
29
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.5
25.3
50
60
R4110
NOMESCO Finland
Physiotherapy
6.0
25.2
97
317
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
17.9
24.1
38
27
C03CA01
ATC
furosemide; systemic
5.8
23.4
87
266
WZC30
NOMESCO Finland
Teaching
6.7
21.9
64
142
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
7.6
21.0
54
99
WX408
NOMESCO Finland
General anesthesy, balanced
5.1
20.9
92
328
I34.01
ICD-10 Finland
Mitral (valve) regurgitation NOS or of specified cause, except rheumatic
55.7
20.8
24
5
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
29.0
20.3
27
11
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
5.1
20.2
84
279
C01AA05
ATC
digoxin; systemic
10.2
19.5
40
50
FGC10
NOMESCO Finland
Annuloplasty of tricuspid valve using prosthetic ring
+∞
19.1
18
*
K78
ICPC
Atrial fibrillation/flutter
7.6
18.7
47
82
K83
ICPC
Heart valve disease NOS
37.8
18.5
23
7
B01AF02
ATC
apixaban; oral
7.0
18.0
48
91
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
71.0
17.1
19
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.8
16.9
35
44
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
8.9
16.8
37
52
XF400
NOMESCO Finland
ECG with 12 standard connections
4.8
16.0
62
182
WX892
NOMESCO Finland
Monitored bed care
6.2
14.4
41
83
AH3
HP
Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery
+∞
13.7
13
*
FKC96
NOMESCO Finland
Other repair of mitral valve for insufficiency
+∞
13.7
13
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.0
13.7
68
245
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.2
13.6
62
208
B01AE07
ATC
dabigatran etexilate; oral
9.0
13.6
29
38
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
9.4
13.5
28
35
B01AF01
ATC
rivaroxaban; oral
4.8
13.1
48
130
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
75.9
12.8
14
*
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
75.9
12.8
14
*
I35.0
ICD-10 Finland
Aortic (valve) stenosis
7.4
12.8
31
50
WX402
NOMESCO Finland
General anaesthesia
4.1
12.5
56
183
C07AA07
ATC
sotalol; systemic
12.5
12.5
22
20
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.1
12.3
55
179
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
18.2
12.0
18
11
K80
ICPC
Cardiac arrhythmia NOS
6.0
12.0
34
68
C01BC04
ATC
flecainide; systemic
8.1
11.6
26
37
K84
ICPC
Heart disease other
11.3
11.4
21
21
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
14.3
10.9
18
14
ZXE20
NOMESCO Finland
More than three and less than five hours
4.0
10.9
49
159
FCA70
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft
+∞
10.5
10
*
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
8.2
10.4
23
32
WW502
NOMESCO Finland
Autotransfusion
28.0
10.0
13
5
B01AB05
ATC
enoxaparin; parenteral
3.0
9.7
75
360
AC4
HP
MVP
32.1
9.5
12
*
FKC00
NOMESCO Finland
Repair of mitral valve for insufficiency using ring
105.8
9.5
10
*
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
23.3
9.5
13
6
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.9
9.3
26
51
Q23.11
ICD-10 Finland
Bicuspid aortic valve
20.0
9.1
13
7
ZXD10
NOMESCO Finland
Scheduled procedure
2.8
9.1
86
464
Z2221
NOMESCO Finland
Medical doctor
3.0
9.0
65
295
Z95.4
ICD-10 Finland
Presence of other heart-valve replacement
52.9
8.8
10
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
5.8
8.6
24
47
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
5.8
8.6
24
47
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
14.0
8.0
13
10
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
8.7
7.8
16
20
C03DA01
ATC
spironolactone; oral
3.9
7.6
32
96
FL1AC
NOMESCO Finland
Left cardioangiography
14.3
7.5
12
9
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
11.6
7.4
13
12
AH2
HP
Treatment of atrial fibrillation by maze surgery or its modification as the only procedure
+∞
7.3
7
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.5
7.2
35
119
TFP34
NOMESCO Finland
Electrophysiological investigation
6.4
7.2
18
31
XF640
NOMESCO Finland
NA
8.1
7.1
15
20
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
4.8
7.1
23
54
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.7
7.0
23
55
I48.4
ICD-10 Finland
Atypical atrial flutter
41.8
6.8
8
*
PD5BD
NOMESCO Finland
Extensive CT of aorta
9.3
6.7
13
15
Z3231
NOMESCO Finland
Registered nurse
2.6
6.6
59
292
PC1BD
NOMESCO Finland
Extensive CT of thoracic aorta
72.5
6.5
7
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
8.7
6.5
13
16
C01BD07
ATC
dronedarone; oral
18.9
6.3
9
5
XF402
NOMESCO Finland
ECG with work load test
3.1
6.3
36
137
FKC20
NOMESCO Finland
Plastic repair of mitral valve leaflet for insufficiency
27.8
6.3
8
*
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
27.8
6.3
8
*
FFM20
NOMESCO Finland
Amputation of atrial appendage
+∞
6.3
6
*
TFP35
NOMESCO Finland
Electroanatomical mapping
8.2
6.3
13
17
I50.9
ICD-10 Finland
Heart failure, unspecified
3.3
6.2
31
107
I48.1
ICD-10 Finland
Persistent atrial fibrillation
9.1
6.2
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022217) INR in Platelet poor plasma by Coagulation assay
115
213
13.30
70.28
40.5
21.3
inr
2.1
1.4
—
6
25
(3032080) INR in Blood by Coagulation assay
171
674
35.34
55.83
22.6
8.5
inr
1.8
1.2
4.23
30
208
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
118
287
10.13
54.46
6.2
4.0
ng/l
4053.7
415.1
4.89
112
241
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
131
364
10.69
53.12
2.3
2.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
43
35
15.85
45.23
2.9
2.1
%
73.8
68.8
0.59
43
35
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
46
55
10.91
37.38
3.9
2.1
u/ml
0.3
0.4
0.99
31
29
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
162
721
14.13
36.80
4.0
4.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
133
494
7.59
36.25
2.6
2.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
75
169
6.92
34.84
12.1
9.3
%
95.3
96.3
0.32
68
164
(3027801) Oxygen [Partial pressure] in Arterial blood
78
186
6.66
34.09
12.0
8.9
kpa
14.8
12.1
1.40
73
180
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
78
186
6.66
34.09
12.1
8.9
kpa
5.1
5.0
0.37
72
179
(3003396) Base excess in Arterial blood by calculation
76
187
6.33
31.87
12.3
9.0
mmol/l
1.3
1.1
0.16
61
152
(3024928) Oxygen saturation in Venous blood
35
36
11.84
31.37
5.2
3.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
91
294
5.26
27.27
5.1
3.8
mmol/l
0.9
0.8
2.01
85
279
(3012544) pH of Venous blood
61
148
5.74
25.35
7.0
4.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
167
959
12.06
23.53
10.2
4.9
mmol/l
6.5
6.7
1.30
162
910
(3000991) Gas panel - Venous blood
56
138
5.45
22.64
8.2
9.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
101
402
4.47
22.14
5.7
4.4
%
66.7
89.0
11.79
101
394
(3019060) Gas panel - Arterial blood
50
117
5.54
21.33
11.7
4.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
99
410
4.17
20.06
1.3
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
130
692
4.21
17.51
10.3
6.3
mmol/l
1.2
1.2
10.25
124
627
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
41
96
5.24
17.25
18.0
10.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
132
743
3.96
15.61
10.9
7.7
mmol/l
1.2
1.2
9.72
126
633
(3002032) Base excess in Venous blood by calculation
48
141
4.29
15.15
4.6
4.3
mmol/l
2.0
1.9
0.14
43
107
(3020891) Body temperature
29
60
5.57
13.87
5.7
4.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
179
1511
+∞
12.27
26.8
15.1
mg/l
41.6
23.9
9.82
173
1219
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
115
653
3.13
12.16
4.6
3.5
ng/l
94.7
37.7
1.08
91
482
(3044889) 12 lead EKG panel
163
1150
5.67
12.14
10.0
4.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
74
336
3.05
11.57
2.7
2.0
mg/l
2.7
3.2
1.21
68
296
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
166
1208
6.15
11.37
8.5
8.5
u/l
78.8
80.2
0.15
166
1134
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
31
81
4.42
11.21
3.8
2.5
%
1.2
1.1
0.05
31
81
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
56
224
3.18
10.81
2.8
2.4
%
23.9
24.1
0.02
47
192
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
34
98
4.05
10.80
7.9
7.9
mmol/l
25.5
24.5
0.89
34
98
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
29
77
4.30
10.25
4.0
2.5
%
0.5
0.6
1.74
29
77
(3023368) Bacteria identified in Blood by Culture
85
450
2.69
9.58
5.1
4.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
76
389
2.66
9.06
5.8
6.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
164
1247
4.76
9.05
41.0
19.5
g/l
329.8
333.8
7.88
164
1240
(3001122) Ferritin [Mass/volume] in Serum or Plasma
97
563
2.58
8.87
3.1
2.5
ug/l
142.1
190.3
0.92
92
514
(3001604) Monocytes [#/volume] in Blood
115
757
2.45
7.57
5.6
6.1
e9/l
0.6
0.6
0.32
94
667
(3006315) Basophils [#/volume] in Blood
115
758
2.45
7.53
5.6
6.2
e9/l
0.0
0.0
0.23
94
674
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
25
75
3.71
7.42
2.5
1.7
g/l
1.1
1.7
1.94
19
65
(3019550) Sodium [Moles/volume] in Serum or Plasma
179
1617
+∞
7.34
40.7
17.3
mmol/l
139.4
139.6
0.71
179
1574
(3019198) Lymphocytes [#/volume] in Blood
116
775
2.41
7.26
5.7
6.2
e9/l
1.7
1.9
0.73
97
697
(3023103) Potassium [Moles/volume] in Serum or Plasma
179
1621
+∞
7.14
40.6
17.5
mmol/l
4.0
4.0
1.86
179
1580
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
23
68
3.73
6.97
2.6
2.3
ug/l
0.5
4.8
0.56
14
63
(3022096) Basophils/100 leukocytes in Blood
106
689
2.32
6.96
5.4
6.3
%
0.6
0.7
0.29
100
654
(3006504) Eosinophils/100 leukocytes in Blood
108
708
2.32
6.94
5.5
6.3
%
3.0
2.8
0.45
102
671
(3018010) Neutrophils/100 leukocytes in Blood
109
719
2.32
6.88
5.6
6.2
%
58.8
57.9
0.33
103
686
(3002030) Lymphocytes/100 leukocytes in Blood
110
731
2.31
6.79
5.7
6.4
%
25.4
26.6
0.63
103
694
(3019069) Monocytes/100 leukocytes in Blood
108
713
2.30
6.76
5.9
6.6
%
9.1
8.9
0.44
102
681
(3024561) Albumin [Mass/volume] in Serum or Plasma
104
676
2.29
6.76
4.9
5.6
g/l
35.2
35.3
0.10
96
640
(3013115) Eosinophils [#/volume] in Blood
115
780
2.33
6.74
6.3
6.3
e9/l
0.2
0.2
0.23
97
700
(3047181) Lactate [Moles/volume] in Blood
19
52
3.97
6.39
25.6
8.5
mmol/l
1.4
1.3
0.21
13
46
(3013650) Neutrophils [#/volume] in Blood by Automated count
124
883
2.32
6.27
7.2
10.0
e9/l
4.2
4.2
0.07
101
782
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
166
1365
3.98
6.15
5.6
4.3
mu/l
2.1
2.0
0.52
159
1221
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
30
119
2.83
5.65
3.4
2.8
ml/min/173m2
64.6
61.3
0.13
14
55
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
172
1512
4.52
5.48
5.1
4.3
mmol/l
1.2
1.4
1.51
166
1371
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
343
2.18
5.40
3.0
1.7
mg/l
2.0
1.3
0.76
49
274
(42870588) Differential panel, method unspecified - Blood
84
534
2.08
5.40
6.0
6.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
52
279
2.22
5.14
2.6
2.7
e6/l
0.5
0.9
1.09
31
168
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
49
260
2.22
4.96
2.6
2.8
e6/l
2.9
1.5
0.32
28
152
(1761868) Lipid panel - Serum or Plasma
30
588
0.41
4.84
2.5
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
33
150
2.47
4.73
2.0
2.7
e9/l
69.5
72.3
0.13
23
115
(3030467) Casts [#/volume] in Urine by Automated count
71
443
2.00
4.66
2.7
3.1
e6/l
0.5
0.5
0.06
50
341
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
25
4.62
4.63
1.2
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
25
4.62
4.63
1.2
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
68
423
1.98
4.46
2.8
3.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
23
91
2.75
4.33
1.0
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
141
1134
2.15
4.26
3.9
4.0
mm/h
12.3
12.0
0.08
133
1042
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
135
1069
2.07
4.25
4.5
3.6
pmol/l
15.5
14.9
1.74
128
940
(3003327) Ova and parasites identified in Stool by Light microscopy
12
32
3.95
4.16
2.3
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
47
263
2.07
4.09
1.8
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
124
963
1.94
4.00
4.0
3.9
—
55.1
—
0
14
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
192
2.17
3.90
1.9
1.9
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
179
1696
+∞
3.80
43.8
21.9
e9/l
7.2
6.7
3.44
179
1645
(3026361) Erythrocytes [#/volume] in Blood
179
1696
+∞
3.80
43.7
21.8
e12/l
4.3
4.6
10.78
179
1644
(3024731) MCV [Entitic volume]
179
1696
+∞
3.80
43.6
21.7
fl
91.2
91.5
0.37
179
1670
(3035941) MCH [Entitic mass]
179
1695
+∞
3.80
43.6
21.7
pg
30.3
30.6
1.78
179
1669
(3007461) Platelets [#/volume] in Blood
179
1694
+∞
3.79
43.6
21.8
e9/l
220.8
239.6
4.38
179
1649
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
36
187
2.16
3.78
1.7
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
16
5.86
3.71
1.7
2.1
%
13.6
12.8
—
9
16
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
87
2.60
3.63
1.2
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
54
331
1.90
3.59
2.8
3.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
179
1697
+∞
3.58
43.8
21.9
g/l
127.5
138.7
16.32
179
1669
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
103
2.41
3.39
1.5
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
71
483
1.78
3.35
2.8
3.1
e6/l
13.8
167.4
0.63
49
382
(3021589) Normoblasts [#/volume] in Blood
94
694
1.75
3.33
7.6
10.7
e9/l
0.0
0.0
0.16
70
588
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
17
67
2.70
3.23
24.4
6.9
%
1.9
1.8
0.14
12
62
(3041096) Erythrocytes [Presence] in Urine by Automated
21
413
0.44
3.16
3.5
3.1
—
—
—
0
0
(3000492) Spirometry study
31
163
2.09
3.15
1.8
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
150
1287
2.02
3.06
38.2
18.4
%
14.1
13.8
1.96
150
1267
(3007853) Bacteria identified in Skin by Aerobe culture
34
189
1.99
2.97
1.5
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
76
542
1.70
2.96
3.5
3.5
e6/l
72.0
38.9
0.44
51
404
(3042936) Bacteria identified in Isolate by Culture
43
260
1.86
2.94
2.2
2.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
209
1.90
2.77
9.6
7.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
165
1491
2.36
2.56
27.1
13.9
ml/min/173m2
78.5
79.9
0.43
154
1233
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
77
574
1.60
2.41
3.0
3.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
28
3.33
2.34
1.1
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
60
2.45
2.28
1.1
1.4
g/l
3.4
3.1
—
9
50
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
25
137
1.96
2.28
3.9
2.9
u/l
37.8
35.9
0.08
20
114
(3037467) Urinalysis macro (dipstick) panel - Urine
123
1032
1.61
2.27
3.4
4.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
48
2.61
2.23
3.0
3.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
156
1398
1.90
2.20
38.7
15.7
%
38.5
40.5
2.67
131
968
(3026493) Urate [Moles/volume] in Serum or Plasma
64
466
1.58
2.17
2.9
2.6
umol/l
363.0
5930.5
1.69
57
402
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
79
612
1.52
2.00
1.9
1.9
pmol/l
96.7
94.9
0.15
37
314
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
12
51
2.45
1.99
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
71
2.21
1.98
1.1
1.2
iu/ml
16.7
101.6
—
5
20
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
101
1.99
1.89
1.2
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
66
2.22
1.87
1.1
1.4
g/l
7.0
7.7
—
9
52
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
66
2.22
1.87
1.1
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
66
2.22
1.87
1.1
1.4
g/l
4.4
3.7
—
9
48
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
17
3.61
1.85
1.2
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
46
322
1.58
1.81
2.0
2.6
e6/l
2.8
3.7
0.39
35
286
(3044941) Cell count panel - Synovial fluid
7
25
2.87
1.66
1.1
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
31
202
1.65
1.62
1.2
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
12
57
2.18
1.59
1.2
2.3
mg/l
26.7
33.7
0.57
12
46
(3034860) Kappa light chains.free [Mass/volume] in Serum
12
57
2.18
1.59
1.2
2.3
mg/l
37.6
152.4
0.53
12
46
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
163
1.70
1.57
1.2
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
44
2.35
1.56
1.2
2.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
39
273
1.55
1.53
1.5
1.6
nmol/l
869.0
1256.8
2.53
31
214
(3000093) Morphology [Interpretation] in Blood Narrative
6
21
2.92
1.52
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
21
2.92
1.52
1.5
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
52
2.19
1.47
2.2
1.5
—
—
—
0
0
(4268621)
5
16
3.18
1.45
3.8
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
40
2.31
1.42
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
24
154
1.64
1.34
1.2
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
115
1.73
1.31
2.5
3.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
19
2.68
1.22
1.0
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
96
831
1.33
1.11
2.4
2.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
21
2.42
1.10
2.0
2.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
52
1.98
1.08
1.5
1.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
9
46
2.01
1.05
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
40
304
1.41
1.05
2.1
2.8
mosm/kgh2o
612.1
589.9
0.20
31
257
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
35
2.04
1.01
1.1
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
49
1.88
1.00
1.3
1.5
—
—
—
0
0
(44790047)
5
23
2.21
0.98
1.6
1.8
—
—
—
0
0
(44790049)
5
23
2.21
0.98
1.6
1.8
—
—
—
0
0
(44790048)
5
23
2.21
0.98
1.6
1.8
—
—
—
0
0
(44806118)
5
23
2.21
0.98
1.6
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
37
1.93
0.95
1.6
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
38
292
1.38
0.94
1.2
1.2
u/ml
0.8
0.8
—
5
86
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
28
2.18
0.92
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
28
2.18
0.92
1.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
111
1.59
0.91
1.2
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
79
1.70
0.91
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
29
2.10
0.90
1.8
2.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
43
1.90
0.88
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
43
1.90
0.88
1.1
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
44
1.86
0.87
1.1
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
73
1.69
0.84
2.8
2.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
48
390
1.32
0.83
2.5
2.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
96
0.51
0.80
1.6
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
24
0.00
0.80
0.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
24
0.00
0.80
0.0
2.5
—
4.3
—
0
24
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
25
0.00
0.79
0.0
3.3
—
58.5
—
0
25
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
48
577
0.77
0.79
3.3
3.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
28
0.00
0.77
0.0
4.7
—
27.7
—
0
19
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
28
0.00
0.77
0.0
1.1
—
7.3
—
0
20
(4094501)
9
54
1.70
0.76
1.1
1.1
—
—
—
0
0
(4034850)
9
55
1.67
0.75
8.6
8.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
38
1.88
0.74
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
56
1.64
0.73
1.9
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
40
1.78
0.72
1.9
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
93
1.55
0.72
1.7
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
63
541
1.25
0.71
2.0
2.2
nmol/l
72.9
75.3
0.31
53
474
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
42
1.69
0.69
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
42
1.69
0.69
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
42
1.69
0.69
1.1
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5
92
0.53
0.69
1.2
1.2
—
16.3
—
0
7
(3021788) Differential panel - Synovial fluid
5
28
1.81
0.66
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
23
173
1.38
0.66
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
44
1.61
0.66
1.4
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
35
282
1.30
0.65
1.4
1.3
g/l
2.6
2.9
0.57
18
178
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
79
1.56
0.64
1.4
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
29
1.74
0.64
2.4
1.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
3.3
—
16.6
—
0
20
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
72
1.56
0.60
1.4
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
22
0.00
0.59
0.0
2.4
—
34.0
—
0
22
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.3
—
67.7
—
0
8
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
38
1.60
0.55
1.3
1.2
—
—
—
0
0
(4010399)
9
136
0.64
0.54
1.2
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
57
498
1.21
0.53
3.3
3.8
mmol/l
2.3
2.3
0.01
46
433
(3019832) Treponema pallidum Ab [Presence] in Serum
9
63
1.45
0.53
1.0
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
7
108
0.63
0.50
3.9
4.2
ng/l
122.9
85.1
—
7
98
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
143
0.68
0.50
2.0
1.9
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
69
1.48
0.45
1.6
4.0
%
68.9
52.3
—
10
69
(3009508) Creatinine [Moles/volume] in Urine
58
519
1.17
0.41
2.7
3.4
mmol/l
7.9
8.4
0.29
51
426
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
16
0.00
0.41
0.0
2.8
—
645.9
—
0
8
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
17
0.00
0.41
0.0
1.9
—
755.2
—
0
8
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
20
160
1.28
0.40
2.4
2.5
g/l
0.2
0.2
1.22
20
146
(40768797) Stomach Pathology biopsy report
25
206
1.25
0.40
1.2
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
34
1.48
0.40
1.4
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
111
1048
1.16
0.38
3.5
3.5
u/l
67.1
58.3
0.51
104
983
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
32
273
1.21
0.38
2.4
3.4
mmol/l
2.4
2.5
0.03
25
237
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
36
1.40
0.38
1.6
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
89
952
0.87
0.38
4.2
4.9
ug/l
1.8
2.4
0.73
82
866
(3012516) Albumin [Mass/volume] in Urine
56
505
1.16
0.36
2.5
3.5
mg/l
2491.1
198.4
0.74
34
344
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
41
1.48
0.36
1.8
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
24
200
1.23
0.36
1.3
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
82
1.36
0.35
2.1
2.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
44
1.38
0.35
1.5
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
74
1.37
0.33
2.2
2.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
78
726
1.13
0.32
3.0
3.4
estimate
0.0
0.0
—
5
152
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
251
1.19
0.31
1.1
1.3
iu/ml
14.5
32.8
1.86
14
82
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
62
1.30
0.28
1.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
37
1.36
0.23
1.4
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
172
1.18
0.23
1.5
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
81
767
1.10
0.23
3.8
4.3
%
26.1
21.1
0.75
31
364
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
88
1.27
0.23
1.3
1.3
—
—
—
0
0
(4035726)
12
146
0.81
0.23
1.9
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.4
—
1.8
—
0
11
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
11
0.00
0.21
0.0
1.8
—
6036.2
—
0
6
(3005570) Glucose [Moles/volume] in Urine
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
11
0.00
0.21
0.0
1.2
—
7.9
—
0
11
(3044242) Glucose [Moles/volume] in Arterial blood
0
10
0.00
0.21
0.0
8.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
18.4
—
0
10
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
4.6
—
102.6
—
0
13
(3016750) Collection duration of Urine
0
13
0.00
0.21
0.0
2.8
—
520.1
—
0
7
(3026470) Cobalt [Mass/volume] in Blood
0
14
0.00
0.20
0.0
2.1
—
4.1
—
0
14
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
78
744
1.09
0.18
3.2
3.4
estimate
0.0
0.0
—
5
147
(3009343) pH of Capillary blood
13
110
1.20
0.17
2.2
2.9
—
7.4
—
0
14
(40768804) Tissue Pathology biopsy report
56
593
0.92
0.17
1.7
2.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
68
1.18
0.17
1.3
1.3
—
—
—
0
0
(1002224) Polysomnography panel
8
71
1.13
0.16
1.4
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
99
0.80
0.14
4.0
1.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
76
731
1.07
0.13
4.5
4.6
estimate
0.0
0.0
—
5
155
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
179
0.88
0.13
2.3
3.2
—
—
—
0
0
(3002256) Pathology report gross observation
22
202
1.10
0.11
1.2
1.3
—
—
—
0
0
(3013512) EKG study
47
492
0.94
0.10
8.5
4.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
44
1.14
0.10
1.4
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
23
214
1.09
0.09
1.4
1.3
titre
240.0
486.2
—
5
45
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
62
0.80
0.08
1.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
74
0.80
0.07
1.7
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
33
345
0.95
0.06
3.5
4.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
24
229
1.06
0.04
1.2
1.3
u/ml
32.0
7.8
—
7
85
(21494755) Public health laboratory ask at order entry panel
11
119
0.92
0.04
1.3
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
55
540
1.03
0.02
2.8
4.2
mg/mmol
17.9
11.4
0.30
34
345
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
56
567
0.98
0.01
2.5
2.9
ug/l
0.7
0.7
0.04
29
381
(3000494) Fungus identified in Specimen by Culture
20
204
0.98
0.00
1.7
1.5
—
—
—
0
0
(3019225) pH of Specimen
15
151
0.99
0.00
3.5
4.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.2
—
3.5
—
0
6
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
164.2
—
0
6
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
1.2
—
0
6
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
52
0.96
0.00
1.2
1.8
pmol/l
187.6
217.8
—
5
47
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
8.2
—
977.4
—
0
5
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(21491868) Cryoglobulin [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.3
—
22.8
—
0
9
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
15.6
—
1331.6
—
0
5
(1617658) Protocol used for examination of sentinel lymph nodes
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
74
0.94
0.00
2.7
3.5
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
136.4
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
62
0.97
0.00
2.5
3.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
42.8
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
-0.00
0.0
2.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
5.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
-0.00
0.0
2.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
-0.00
0.0
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
-0.00
0.0
2.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AF_ABLATION – Surgical ablation of atrial fibrillation
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).